What’s Trending in the $66 Billion Global Telehealth and Remote Patient Monitoring Market

Digitally-enabled care, including remote patient monitoring and telehealth/telemedicine, is taking center stage in the healthcare environment. Nearly $66 billion was spent on patient monitoring and telehealth equipment, devices, and services worldwide during 2023, up from $46 billion in 2018, reports leading medical market researcher Kalorama Information in the new report, Remote Patient Monitoring and Telehealth […]

Molecular Oncology Test Sales Reach $6 Billion

One of the most explored applications of molecular diagnostics is oncology, a segment with sales exceeding $6 billion in 2023, according to new data published in Molecular Diagnostics in Oncology, Genetic/Inherited Diseases, and NIPT, 2023-2028, now on sale by leading medical and diagnostic market research firm Kalorama Information. In the report, the oncology segment is […]

Cell and Gene Therapy: $27 Billion in Q1-Q3 2023 Funding

The concepts of cell therapy and gene therapy have been investigated for decades, but there were major challenges in the early years. Through incremental progress, and the gradual introduction of enabling tools such as CRISPR and next-generation sequencing (NGS), cell and gene therapy has emerged into a highly active area. There are now many approved […]

Global Medtech Sales Exceed $500 Billion as Chronic Diseases Shape Market’s Future

“Advances in Medtech can enhance patient treatment, improve outcomes, lower hospital admissions and fatalities, achieve cost savings, and alleviate the workload on healthcare staff, thus creating a market for medical devices that is forecast to grow and expand over the next five years.“ – Kalorama Information The world market for Medtech is valued at over $500 billion […]

Healthcare Advances, Investments Support Laboratory Information System (LIS) Growth

The global market for LIS is forecast to increase at a high single-digit compound annual growth rate (CAGR) between 2022 and 2027, reveals leading medical market research publisher Kalorama Information in the new report World Market for Laboratory Information Systems (LIS): Software, Hardware, and Implementation for Clinical Labs, 2022-2027. Advances in healthcare will function as […]

Personalized Medicine Key to IVD Procedure Volumes’ 10% Annual Growth

The in vitro diagnostic (IVD) industry is on track again after the disruptions of the pandemic. The overall volume of IVD procedures will rise steadily throughout most of the world, boosted by aging population trends, proliferating epidemiological patterns, increasing availability of healthcare funding, and widespread adoption of patient care strategies that emphasize early disease detection […]

RNA Sequencing: Life Sciences’ Transformative $2.6 Billion Industry

The RNA sequencing market continues to offer potent tools with the potential to usher in significant transformations in healthcare in the foreseeable future. Over the past decade, there has been a remarkable surge in product launches, novel applications, and a rush of end-user labs eager to become major competitors in this $2.6 billion industry, according […]

How Globalization and Climate Change Impact COVID-19 and the IVD Market

COVID-19 hospitalizations in the U.S. have spiked in recent weeks amidst the advent of yet another new variant and the impending arrival of updated booster shots for a fall vaccination campaign. This late summer spike in infections comes after months of declines in COVID-related hospitalizations and deaths. The spike is poised to impact the in […]

IVD Trends 2023-2028: Emerging Growth Markets in Asia, Latin America, and the Middle East

In vitro diagnostic (IVD) testing is truly global as it has impacted every country in the world due to COVID-19 and it will continue to play an ever-increasing role in the practice of medicine. Social and economic events in selected countries will continue to influence the IVD market, but overall the IVD market plays an […]

Worldwide IVD: 8 Key Trends to Watch in $106 Billion Market

In vitro diagnostics (IVDs) remain dynamic. The IVD market is a high R&D spend industry with constant innovations and routine interest from venture capital firms in diagnostic products.  Nevertheless, the past few years have been very disruptive for IVDs.  However, the resilient IVD industry has weathered the pandemic and is forging ahead with new technologies […]